Table 1

Observed and expected number of deaths and standardised mortality ratios (SMR) by gender, disease course and periods for disease at onset, period for diagnosis, age at onset and age at diagnosis for patients with multiple sclerosis (MS) in Hordaland

GroupNObserved, n (%)Expected, n (%)SMR(95 % CI)p-value (log-rank)
All patients1388291 (21.0)107.3 (7.7)2.72.4 to 3.0<0.0001
Gender0.0009
 Male533131 (24.6)52.6 (9.9)2.52.1 to 2.9
 Female855160 (18.7)54.7 (6.4)2.92.5 to 3.4
Course of disease at onset<0.0001
 RRMS1209202 (16.7)84.4 (7.0)2.42.1 to 2.7
 PPMS17989 (49.7)23.0 (12.8)3.93.1 to 4.7
Period for onset0.0083
 1953–1974237155 (65.4)49.8 (21.0)3.12.6 to 3.6
 1975–1996638130 (20.4)49.4 (7.7)2.62.2 to 3.1
 1997–20125136 (1.1)8.1 (1.6)0.70.3 to 1.5
Period for diagnosis<0.0001
 1953–1974136100 (73.5)33.4 (24.6)32.5 to 3.6
 1975–1996602178 (29.6)58.3 (9.7)3.12.6 to 3.5
 1997–201265013 (2.0)15.7 (2.4)0.80.5 to 1.4
Age at onset (years)<0.0001
 2010720 (18.7)2.7 (2.5)7.34.5 to 10.9
 21–3047190 (19.1)22.3 (4.7)43.3 to 4.9
 31–4045990 (19.6)35.2 (7.7)2.62.1 to 3.1
 41–5024661 (13.4)28.2 (6.2)2.21.7 to 2.8
 51–609225 (27.2)15.0 (16.3)1.71.1 to 2.4
 61+135 (38.5)3.9 (3.0)1.30.5 to 2.8
Age at diagnosis (years)0.0043
 20496 (12.2)0. 7 (1.4)93.6 to 18.3
 21–3032757 (17.4)10.6 (3.2)5.44.1 to 6.9
 31–4045490 (19.8)25.5 (5.6)3.52.9 to 4.3
 41–5035681 (22.8)37.0 (10.4)2.21.7 to 2.7
 51–6016142 (26.1)24.3 (15.1)1.71.3 to 2.3
 61+4115 (36.6)9.2 (22.4)1.60.9 to 2.6
  • PPMS, primary progressive MS; RRMS, relapsing-remitting MS.